News
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...
A team of scientists has uncovered the remarkable potential of a human antibody, mAb 3A6, in fighting Ebola virus infections.
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.
Researchers have uncovered a critical, previously underappreciated role for B cells in vaccine protection. Best known for producing antibodies, B cells also guide other immune cells, specifically CD8 ...
Researchers at the University of Colorado Anschutz Medical Campus have uncovered a critical, previously underappreciated role ...
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of ...
Antibody Solutions, a leading provider of fit-for-purpose antibody discovery services, announced today that for the first ...
OmniAb, Inc. today announced the appointments of Philip J. Gotwals, Ph.D., and Steve Crouse to its Board of Directors. OmniAb also announced the departure of Director Sarah Boyce, who is stepping down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results